US Broker Ratings

Fresenius Medical Care AG (FMS) Stock Analysis: An Insightful Look at Growth Potential and Market Position

Fresenius Medical Care AG (FMS) stands as a pivotal player in the healthcare sector, specifically within the medical care facilities industry. With a market cap of $15.99 billion, the company..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A 21.57% Upside Potential in the Booming Biotechnology Sector

For investors with a keen eye on the healthcare industry, Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) presents a compelling opportunity within the biotechnology sector. Known for its innovative therapeutic approaches, Madrigal..

Cencora, Inc. (COR) Stock Analysis: Riding High on Healthcare with a 116.71% ROE

Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector specializing in medical distribution, has been capturing investor attention with its robust return on equity (ROE) of 116.71%. As the..

Incyte Corporation (INCY) Stock Analysis: Navigating a 16.5% Revenue Growth Amidst Market Volatility

Incyte Corporation (INCY), a prominent player in the biotechnology industry, is capturing investor attention with its robust revenue growth of 16.5%. With a market capitalization of $17.82 billion, Incyte stands..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unlocking 94% Upside Potential with Innovative Radiopharmaceuticals

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising portfolio of radiopharmaceutical products. Headquartered in North Melbourne, Australia, this..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Powerhouse with 27.82% Upside Potential

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, is drawing significant attention from investors, thanks to its strong growth metrics and promising future outlook. The..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Insights into a Biotech Powerhouse with 100% Revenue Growth

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, has been making waves with its impressive 100.70% revenue growth, capturing the attention of investors and analysts alike...

Alkermes plc (ALKS) Stock Analysis: Discovering a 46.76% Upside Potential in the Biopharma Space

Investors seeking opportunities in the healthcare sector might find Alkermes plc (NASDAQ: ALKS) an intriguing prospect given its significant upside potential. With a market capitalization of $4.92 billion, this Ireland-based..

Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Giant with a 6.39% Potential Upside

Doximity, Inc. (NASDAQ: DOCS) is a formidable player in the healthcare technology space, providing an essential digital platform tailored for medical professionals. Headquartered in San Francisco, Doximity has carved out..

Globus Medical, Inc. (GMED)

⚠️ No article content returned.

..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 25% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing the attention of investors in the healthcare sector, thanks to its strong growth metrics and favorable analyst ratings. With a market capitalization..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Assessing a 48% Potential Upside Opportunity

Lantheus Holdings, Inc. (NASDAQ: LNTH), a significant player in the healthcare sector specializing in the development and commercialization of diagnostic and therapeutic products, is capturing investor attention with a notable..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Leader with Strong Revenue Growth and Analyst Support

Investors with a keen eye on the healthcare sector should take a closer look at The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the medical care facilities industry...

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Biotech Giant with 10% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) has emerged as a key player in the biotechnology sector, offering a unique investment opportunity with its robust pipeline and strategic focus on developing breakthrough..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 9% Potential Downside Amidst Steady Growth

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specializes in medical devices with a focus on life science research and clinical diagnostics. With a market capitalization..

Bio-Techne Corp (TECH) Stock Analysis: A Closer Look at Its Growth Potential and Analyst Ratings

Bio-Techne Corporation (NASDAQ: TECH) stands as an intriguing player in the biotechnology sector, drawing investor interest due to its robust market presence and strategic positioning in the healthcare landscape. With..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 26.99% Upside Potential in the Biotech Sector

Nuvalent, Inc. (NASDAQ: NUVL) is garnering significant attention from investors in the biotechnology sector. As a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, Nuvalent is dedicated to developing targeted therapies..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and Promising 8.68% Upside

Exact Sciences Corporation (NASDAQ: EXAS) has established itself as a significant player in the healthcare sector, specifically within the diagnostics and research industry. The company’s innovative cancer screening and diagnostic..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: 74% Potential Upside Ignites Investor Interest

For investors seeking opportunities in the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents a compelling case. With a market capitalization of $10.46 billion, this San Rafael, California-based company focuses..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring 9.59% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NASDAQ: STVN), a notable player in the healthcare sector, has been gaining traction among investors with its robust portfolio of medical instruments and supplies. Headquartered in Piombino..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds